Stay updated with breaking news from Performance Enzymes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
These five stocks that Cathie Wood's ARK funds own millions of shares of are perfect for aggressive investors who look to get share count leverage on companies that have sizable upside potential.
Codexis (NASDAQ:CDXS – Get Free Report) released its earnings results on Thursday. The biotechnology company reported ($0.17) EPS for the quarter, beating the consensus estimate of ($0.21) by $0.04, Briefing.com reports. The firm had revenue of $21.32 million for the quarter, compared to analysts’ expectations of $19.83 million. Codexis had a negative net margin of […]
StockNews.com lowered shares of Codexis (NASDAQ:CDXS – Free Report) from a hold rating to a sell rating in a research report sent to investors on Friday morning. A number of other research analysts have also recently commented on the stock. Stephens reissued an overweight rating and issued a $6.00 target price on shares of Codexis […]
Codexis, Inc. (NASDAQ:CDXS – Free Report) was the target of a large decrease in short interest during the month of June. As of June 15th, there was short interest totalling 3,140,000 shares, a decrease of 19.9% from the May 31st total of 3,920,000 shares. Based on an average trading volume of 908,100 shares, the days-to-cover […]
Codexis (NASDAQ:CDXS – Get Rating) and Verde Clean Fuels (NASDAQ:VGAS – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and dividends. Analyst Recommendations This is a breakdown of recent ratings […]